tiprankstipranks
Trending News
More News >
Global Medical REIT Inc (GMRE)
:GMRE
US Market

Global Medical REIT (GMRE) Ratios

Compare
778 Followers

Global Medical REIT Ratios

GMRE's free cash flow for Q1 2025 was $0.78. For the 2025 fiscal year, GMRE's free cash flow was decreased by $ and operating cash flow was $0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.00 2.25 0.05 0.05 0.04
Quick Ratio
0.00 2.25 0.10 0.05 -0.06
Cash Ratio
0.00 0.04 <0.01 0.01 0.01
Solvency Ratio
0.09 0.12 0.13 0.12 0.09
Operating Cash Flow Ratio
0.00 2.28 0.11 0.13 0.06
Short-Term Operating Cash Flow Coverage
0.00 168.99 0.12 0.13 0.07
Net Current Asset Value
$ -717.94M$ -594.27M$ -713.67M$ -600.96M$ -621.88M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.49 0.50 0.45 0.53
Debt-to-Equity Ratio
0.00 1.06 1.10 0.92 1.32
Debt-to-Capital Ratio
0.00 0.51 0.52 0.48 0.57
Long-Term Debt-to-Capital Ratio
0.00 0.51 0.52 0.48 0.57
Financial Leverage Ratio
2.45 2.17 2.20 2.03 2.48
Debt Service Coverage Ratio
3.21 3.57 0.11 0.12 0.06
Interest Coverage Ratio
1.14 1.23 1.54 1.88 0.89
Debt to Market Cap
0.00 0.84 2.14 1.01 1.82
Interest Debt Per Share
0.43 9.91 10.99 9.75 13.08
Net Debt to EBITDA
-0.06 5.53 7.15 6.72 10.96
Profitability Margins
Gross Profit Margin
78.63%80.07%81.65%86.64%88.41%
EBIT Margin
26.88%37.34%32.94%32.81%17.26%
EBITDA Margin
67.40%79.21%70.28%72.45%56.54%
Operating Profit Margin
23.98%26.87%28.28%32.02%17.65%
Pretax Profit Margin
5.88%15.42%14.57%15.82%-2.67%
Net Profit Margin
5.76%14.63%-3.81%-1.79%-21.98%
Continuous Operations Profit Margin
5.88%15.42%14.57%15.82%-2.67%
Net Income Per EBT
97.88%94.84%-26.18%-11.31%824.53%
EBT Per EBIT
24.53%57.40%51.50%49.41%-15.10%
Return on Assets (ROA)
0.63%1.63%-0.38%-0.16%-1.87%
Return on Equity (ROE)
1.48%3.53%-0.83%-0.33%-4.63%
Return on Capital Employed (ROCE)
2.61%3.06%5.34%5.13%2.96%
Return on Invested Capital (ROIC)
20.52%3.06%-0.75%-0.34%12.62%
Return on Tangible Assets
0.71%1.70%-0.42%-0.18%-2.07%
Earnings Yield
1.88%2.83%-0.84%-0.19%-3.41%
Efficiency Ratios
Receivables Turnover
17.02 4.20 16.66 18.60 16.45
Payables Turnover
0.00 2.20 1.82 1.50 1.49
Inventory Turnover
0.00 0.00 -0.73 -12.53 0.21
Fixed Asset Turnover
0.00 12.84 39.45 30.44 26.05
Asset Turnover
0.11 0.11 0.10 0.09 0.09
Working Capital Turnover Ratio
-0.43 -0.47 -0.24 -0.22 -0.22
Cash Conversion Cycle
21.44 -79.31 -681.25 -253.28 1.51K
Days of Sales Outstanding
21.44 86.81 21.91 19.62 22.19
Days of Inventory Outstanding
0.00 0.00 -502.91 -29.13 1.73K
Days of Payables Outstanding
0.00 166.12 200.25 243.77 244.49
Operating Cycle
21.44 86.81 -481.00 -9.51 1.75K
Cash Flow Ratios
Operating Cash Flow Per Share
1.02 1.04 1.17 1.14 0.75
Free Cash Flow Per Share
0.24 0.89 -1.22 -2.19 -3.98
CapEx Per Share
0.78 0.15 2.39 3.33 4.73
Free Cash Flow to Operating Cash Flow
0.24 0.85 -1.04 -1.92 -5.34
Dividend Paid and CapEx Coverage Ratio
0.58 0.91 0.35 0.27 0.13
Capital Expenditure Coverage Ratio
1.31 6.81 0.49 0.34 0.16
Operating Cash Flow Coverage Ratio
0.00 0.11 0.11 0.12 0.06
Operating Cash Flow to Sales Ratio
0.49 0.49 0.56 0.59 0.37
Free Cash Flow Yield
3.82%8.03%-12.84%-12.33%-30.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
53.21 35.30 -118.57 -518.98 -29.32
Price-to-Sales (P/S) Ratio
3.06 5.16 4.52 9.28 6.45
Price-to-Book (P/B) Ratio
0.82 1.25 0.98 1.73 1.36
Price-to-Free Cash Flow (P/FCF) Ratio
26.15 12.46 -7.79 -8.11 -3.28
Price-to-Operating Cash Flow Ratio
6.21 10.63 8.11 15.61 17.50
Price-to-Earnings Growth (PEG) Ratio
-6.97 -0.09 -0.89 5.62 -0.34
Price-to-Fair Value
0.82 1.25 0.98 1.73 1.36
Enterprise Value Multiple
4.49 12.05 13.58 19.54 22.36
Enterprise Value
417.26M 1.35B 1.31B 1.64B 1.19B
EV to EBITDA
4.49 12.05 13.58 19.54 22.36
EV to Sales
3.02 9.55 9.55 14.15 12.64
EV to Free Cash Flow
25.82 23.04 -16.45 -12.37 -6.43
EV to Operating Cash Flow
6.13 19.66 17.12 23.79 34.33
Tangible Book Value Per Share
5.84 8.42 7.56 8.31 7.64
Shareholders’ Equity Per Share
7.74 8.90 9.67 10.27 9.62
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 1.26 1.11 -7.25
Revenue Per Share
2.06 2.15 2.10 1.91 2.03
Net Income Per Share
0.12 0.31 -0.08 -0.03 -0.45
Tax Burden
0.98 0.95 -0.26 -0.11 8.25
Interest Burden
0.22 0.41 0.44 0.48 -0.15
Research & Development to Revenue
0.00 0.00 <0.01 <0.01 >-0.01
SG&A to Revenue
0.15 0.12 0.12 0.14 0.32
Stock-Based Compensation to Revenue
0.03 0.03 0.03 0.05 0.06
Income Quality
8.43 3.32 3.83 3.76 -13.81
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis